Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Senores Pharmaceuticals Financial Results

Senores Pharmaceuticals reported audited FY26 consolidated total income of ₹679.89 Crore. The board also noted the resignation of the Company Secretary effective June 10, 2026.

Source

NSE filing, NSE: SENORES. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Senores Pharmaceuticals Ltd: key numbers

Share price
₹1,324.30
Market cap
₹6,099 Cr
Revenue (annual)
₹632.6 Cr
Net profit (annual)
₹115.4 Cr
P/E (TTM)
48.3×Sector 46.1×
Promoter holding
45.82%+0.00% QoQ
FII holding
6.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Senores Pharmaceuticals Ltd

All →

Other financial results announcements

All →